Back to Search
KAREN BALLEN, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1821089558IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology
Code: 207RH0000X
0101261336(VA)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
OTHER
Class of 1982
Research & Publications (20)
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
PMID 19159415·Transfusion·2009
3-trial
Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.
PMID 19203728·Biol Blood Marrow Transplant·2009
8-other
Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma.
PMID 18794868·Bone Marrow Transplant·2009
8-other
New trends in transplantation: the use of Thymoglobulin.
PMID 19292599·Expert Opin Drug Metab Toxicol·2009
6-review
Collection and preservation of cord blood for personal use.
PMID 18275904·Biol Blood Marrow Transplant·2008
6-review
Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
PMID 18721775·Biol Blood Marrow Transplant·2008
6-review
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
PMID 18804043·Biol Blood Marrow Transplant·2008
4-observational
Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT.
PMID 18587439·Bone Marrow Transplant·2008
3-trial
Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide.
PMID 18721762·Biol Blood Marrow Transplant·2008
4-observational
Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.
PMID 18316568·Clin Cancer Res·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1240 LEE ST
CHARLOTTESVILLE, VA 22908 - Phone
- (434) 924-9333
Quick Facts
- NPI
- 1821089558
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 3
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile